ES364421A1 - Procedimiento de preparacion de nuevos derivados de la n-a-mino indolina sustituida. - Google Patents

Procedimiento de preparacion de nuevos derivados de la n-a-mino indolina sustituida.

Info

Publication number
ES364421A1
ES364421A1 ES364421A ES364421A ES364421A1 ES 364421 A1 ES364421 A1 ES 364421A1 ES 364421 A ES364421 A ES 364421A ES 364421 A ES364421 A ES 364421A ES 364421 A1 ES364421 A1 ES 364421A1
Authority
ES
Spain
Prior art keywords
disubstituted
alkyl
signifies
indoline compounds
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES364421A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Publication of ES364421A1 publication Critical patent/ES364421A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ES364421A 1968-03-06 1969-03-05 Procedimiento de preparacion de nuevos derivados de la n-a-mino indolina sustituida. Expired ES364421A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB00906/68A GB1203691A (en) 1968-03-06 1968-03-06 New disubstituted n-amino indoline derivatives and process for preparing them

Publications (1)

Publication Number Publication Date
ES364421A1 true ES364421A1 (es) 1971-02-01

Family

ID=9976474

Family Applications (1)

Application Number Title Priority Date Filing Date
ES364421A Expired ES364421A1 (es) 1968-03-06 1969-03-05 Procedimiento de preparacion de nuevos derivados de la n-a-mino indolina sustituida.

Country Status (13)

Country Link
US (1) US3565911A (enExample)
BE (1) BE728658A (enExample)
CH (1) CH507940A (enExample)
DE (1) DE1909180A1 (enExample)
DK (1) DK126193B (enExample)
ES (1) ES364421A1 (enExample)
FI (1) FI50119C (enExample)
FR (1) FR2003311A1 (enExample)
GB (1) GB1203691A (enExample)
IT (1) IT8049196A0 (enExample)
NL (1) NL145226B (enExample)
NO (1) NO128068B (enExample)
SE (1) SE334887B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112111A (en) * 1975-02-26 1978-09-05 Sandoz Ltd. Indolinylguanidines
IT1113879B (it) * 1979-03-15 1986-01-27 Farmatis Spa Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
LU82949A1 (fr) * 1980-11-20 1981-06-04 Usv Pharma Corp Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension
DE3172386D1 (en) * 1980-12-22 1985-10-24 Usv Pharma Corp Synthesis of indolines
JPS57206657A (en) * 1981-06-16 1982-12-18 Mitsui Toatsu Chem Inc Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component
FR2529785A1 (fr) * 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
FR2663325B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique.
FR2663324B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
AU2005306629A1 (en) * 2004-11-15 2006-05-26 Nicox S.A. Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
FR2924713B1 (fr) * 2007-12-11 2010-01-29 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2011149438A1 (en) 2010-05-28 2011-12-01 Mahmut Bilgic Combination of antihypertensive agents
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
PL3911648T3 (pl) 2019-01-18 2025-03-10 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksy)-2- pirymidynylo]amino]cyklopentylo]amino][1(2h),3'-bipirydyn]-2-on jako inhibitor pcsk9 i sposoby jego zastosowania
TW202314018A (zh) * 2021-06-21 2023-04-01 荷蘭商Asm Ip私人控股有限公司 用於形成包含氧化銦鎵鋅的層之反應器系統及方法
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide
EP4374855A1 (en) 2022-11-22 2024-05-29 KRKA, D.D., Novo Mesto Pharmaceutical dosage form of candesartan and indapamide
EP4559899A1 (en) 2023-11-21 2025-05-28 KRKA, d.d., Novo mesto Synthesis of 1-amino-2-methyl-2,3-dihydroindole by nitrosating 2-methyl-2,3-dihydro-1h-indole and then reducing the obtained 1-nitroso-2-methyl-2,3-dihydroindole with thiourea dioxide

Also Published As

Publication number Publication date
NL6903421A (enExample) 1969-09-09
FI50119B (enExample) 1975-09-01
GB1203691A (en) 1970-09-03
FR2003311A1 (enExample) 1969-11-07
IT8049196A0 (it) 1980-07-09
US3565911A (en) 1971-02-23
DE1909180A1 (de) 1970-07-02
NO128068B (enExample) 1973-09-24
CH507940A (fr) 1971-05-31
NL145226B (nl) 1975-03-17
DK126193B (da) 1973-06-18
BE728658A (enExample) 1969-08-19
FI50119C (fi) 1975-12-10
SE334887B (enExample) 1971-05-10

Similar Documents

Publication Publication Date Title
ES364421A1 (es) Procedimiento de preparacion de nuevos derivados de la n-a-mino indolina sustituida.
ES362717A1 (es) Procedimiento para la preparacion de pesticidas.
ES424378A1 (es) Un procedimiento para la preparacion de nuevos derivados depiridina.
ES389371A1 (es) Procedimiento para la obtencion de derivados de 1-(1,3,4- tiadiazol-2-il)-imidazolidinona-(2).
GR33831B (el) Οργανικαι φωταγωγοι συνθεσεις.
ES428385A1 (es) Procedimiento para la preparacion de derivados de indol.
FR2361889A1 (fr) Nouveaux derives de 1-(benzazolyalcoyl)piperidine
ES361530A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi 3-sec - alcohilamino propanos racemicos u opticamente activos.
GB1374979A (en) 3,5-dioxopiperazine derivatives
ES409436A1 (es) Un procedimiento para la preparacion de nuevos derivados deisoindolina.
GB1230087A (enExample)
ES361741A1 (es) Procedimiento para la preparacion de derivados de benceno.
ES350203A1 (es) Procedimiento para la preparacion de nuevas 5-fenil-1,5- benzodiazepin- 2,4-dionas.
ES322791A1 (es) Un procedimiento para la preparacion de 1, 5, 9-ciclododecatrieno.
GB1234128A (enExample)
DK351783D0 (da) 1-piperazinocarboxylater, deres fremstilling og deres anvendelse i farmaceutiske praeparater
ES400879A1 (es) Procedimiento para la obtencion de derivados de triazolil- etenil-fenileno.
GB1272340A (en) Derivatives of neriifolin
GB1132114A (en) Novel substituted benzimidazoles
ES423484A1 (es) Procedimiento para la obtencion de derivados de estilbeno que contienen grupos sulfo.
ES425628A1 (es) Procedimiento de preparacion de derivados de piperidina sustituidos con amino.
ES349555A1 (es) Un procedimiento para la preparacion de mucononitrilos.
ES371932A1 (es) Un procedimiento para preparar una nueva composiciun procedimiento para preparar nuevos derivados de n-fenil-maleimida. on micro-bicida.
ES374154A1 (es) Un procedimiento de preparar una composicion para combatir roedores indeseables.
FR917529A (fr) Stabilisation de composés halogénés organiques de poids moléculaire élevé